NCT01583218 2023-08-07APEXAlexion Pharmaceuticals, Inc.Phase 3 Completed7,513 enrolled 18 charts 1 FDA
NCT02444572 2021-07-29ENOXACARELes Laboratoires des Médicaments StérilesPhase 4 Completed168 enrolled
NCT01839487 2020-07-20PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic CancerHalozyme TherapeuticsPhase 2 Completed279 enrolled 19 charts
NCT01444612 2017-05-16Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related SurgeryGlaxoSmithKlineCompleted4,068 enrolled
NCT00723216 2010-04-05Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer SurgerySanofiPhase 3 Completed151 enrolled